Drugs / SugarDown
last change Oct 2014 re-read 3 minutes ago

SugarDown

Developed for
type 2 diabetes mellitus
Investigated by
Boston Therapeutics

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02135549 May → Oct 2014 type 2 diabetes mellitus Boston Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SugarDown “SugarDown 4 gram dose in tablet form, before meals, daily for one week” NCT02135549 ↗